Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0046 | 0.0169 | 0.0573 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.013 | 0.2955 | 0.2833 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.013 | 0.2955 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.013 | 0.2955 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.013 | 0.2955 | 0.2833 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.013 | 0.2955 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.013 | 0.2955 | 0.2833 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0046 | 0.0169 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0295 | 0.0999 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.013 | 0.2955 | 0.2833 |
Echinococcus multilocularis | tumor protein p63 | 0.0342 | 1 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.005 | 0.0295 | 0.0999 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0169 | 0.0573 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0046 | 0.0169 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0046 | 0.0169 | 0.5 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0046 | 0.0169 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0634 | 0.2144 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.013 | 0.2955 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0046 | 0.0169 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0169 | 0.0573 |
Schistosoma mansoni | fusion | 0.0046 | 0.0169 | 0.0573 |
Onchocerca volvulus | 0.005 | 0.0295 | 0.0453 | |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0046 | 0.0169 | 0.0573 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0046 | 0.0169 | 0.0573 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.0169 | 0.0573 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0634 | 0.2144 |
Brugia malayi | brahma associated protein 60 kDa | 0.013 | 0.2955 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0046 | 0.0169 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.013 | 0.2955 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0169 | 0.0573 |
Schistosoma mansoni | zinc finger protein | 0.0046 | 0.0169 | 0.0573 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0046 | 0.0169 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.013 | 0.2955 | 0.5 |
Schistosoma mansoni | RNA binding protein | 0.0046 | 0.0169 | 0.0573 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0046 | 0.0169 | 0.0573 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.013 | 0.2955 | 1 |
Onchocerca volvulus | 0.013 | 0.2955 | 1 | |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.013 | 0.2955 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.013 | 0.2955 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.013 | 0.2955 | 0.2833 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.013 | 0.2955 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.013 | 0.2955 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.013 | 0.2955 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0046 | 0.0169 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0169 | 0.0573 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0634 | 0.2144 |
Schistosoma mansoni | hypothetical protein | 0.013 | 0.2955 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0634 | 0.2144 |
Plasmodium vivax | hypothetical protein, conserved | 0.013 | 0.2955 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.013 | 0.2955 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0046 | 0.0169 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.013 | 0.2955 | 0.2833 |
Chlamydia trachomatis | DNA topoisomerase I | 0.013 | 0.2955 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0046 | 0.0169 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.0046 | 0.0169 | 0.0573 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0169 | 0.0573 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0046 | 0.0169 | 0.0573 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.013 | 0.2955 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 56.2341 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.